• Mutation; HGNC; 11998; TP53; Simple; p.Val172Leufs*2 (c.514delG); Zygosity=Unspecified (PubMed=12820372).
  

PubMed=2983887
Saksela K.M., Bergh J., Lehto V.-P., Nilsson K., Alitalo K.
Amplification of the c-myc oncogene in a subpopulation of human small cell lung cancer.
Cancer Res. 45:1823-1827(1985)

PubMed=2990154; DOI=10.1111/j.1699-0463.1985.tb03932.x
Bergh J., Nilsson K., Ekman R., Giovanella B.C.
Establishment and characterization of cell lines from human small cell and large cell carcinomas of the lung.
Acta Pathol. Microbiol. Immunol. Scand. A. 93:133-147(1985)

PubMed=9551745; DOI=10.1183/09031936.98.11020400
Bredin C.G., Sundqvist K.-G., Hauzenberger D., Klominek J.
Integrin dependent migration of lung cancer cells to extracellular matrix components.
Eur. Respir. J. 11:400-407(1998)

PubMed=12820372
Bergqvist M., Brattstrom D., Gullbo J., Hesselius P., Brodin O., Wagenius G.
p53 status and its in vitro relationship to radiosensitivity and chemosensitivity in lung cancer.
Anticancer Res. 23:1207-1212(2003)

PubMed=21508355
Hedman M., Bergqvist M., Brattstrom D., Brodin O.
Fractionated irradiation of five human lung cancer cell lines and prediction of survival according to a radiobiology model.
Anticancer Res. 31:1125-1130(2011)